Med Business World

Your source for healthcare business

Autonomous blood drawing device
Doctor Dispatch

Vitestro starts largest-scale clinical trial globally for its autonomous blood drawing device, with enrolment of first patients in A.D.O.P.T.

Vitestro, expert in medical robotics, has launched the A.D.O.P.T. Trial for its autonomous blood drawing device (image). With an anticipated sample size of over 10,000 patients, this is the most significant study globally to date of autonomous blood collection. Vitestro expects to obtain CE marking by the end of 2024.

The first 350 patients have currently been enrolled the A.D.O.P.T. (Autonomous Optimization and Performance Tests for Blood Testing) Trial at study site Result Laboratorium in the Albert Schweitzer Hospital. Investigational partners, in addition to Result Laboratorium – Albert Schweitzer Hospital, are St. Antonius, OLVG Lab and Amsterdam UMC.

Vitesro’s device combines AI-based, ultrasound-guided 3D reconstruction with the robotic insertion of a needle, ensuring accurate, consistent venipuncture. A prototype has previously been tested with 1,500 patients.

Toon Overbeeke, Founder and CEO at Vitestro, says: “The A.D.O.P.T. Trial is a two-year study. Our objective is to test and continue developing Vitestro’s autonomous venipuncture device and achieve performance and safety results required for regulatory approval.”

Subsequent to this study, Vitestro expects to obtain CE marking on the device they developed to enable autonomous venipuncture with patients.

Result Laboratorium

Since the beginning of operations in 2017, Result Laboratorium in the Albert Schweitzer Hospital has been collaborating with Vitestro. Michael Fouraux, Principal Investigator at Result Laboratorium, says: “Both patients and phlebotomists are very excited about this particular innovation. The A.D.O.P.T. trial heralds a new phase in which we prepare for implementation in routine clinical practice.”

Patients can opt to have their blood drawn by the device and complete the process independently under the supervision of trained healthcare personnel. Fouraux continues: “The degree of professionalism and energy that the Vitestro team brings along really makes a difference and ensures we find our team and patients more than willing to collaborate. Our organizations just click very well together. In recent years, hundreds of patients at this location have already participated in various tests with the blood collection device.”

This innovation in phlebotomy will complement the conventional method of collecting blood samples manually. Implemented devices are intended to compensate the shortage of personnel, making it easier to organize the busy Outpatient Blood Draw Clinic.



Your email address will not be published. Required fields are marked *